比较竞争性结肠镜检查肠道准备方案的真实世界有效性:一项前瞻性试验结果
这项前瞻性、无商业资助的比较有效性研究纳入了在大医疗中心接受门诊结肠镜检查的成人患者,比较了多种肠道准备方案的耐受性和肠道清洁质量。结果显示,与GoLYTELY相比,Suprep、MoviPrep和MiraLAX联合Gatorade的波士顿肠道准备量表总分更高,且多种方案耐受性更优。分次给药与更好的清洁相关,而男性、阿片类和三环类抗抑郁药使用者、糖尿病和肝硬化患者清洁更差。
要点
- Suprep、MoviPrep和MiraLAX联合Gatorade的波士顿肠道准备量表总分高于GoLYTELY。
- 镁 citrate、MiraLAX联合Gatorade、MoviPrep、OsmoPrep、Prepopik/Clenpiq和Suprep的耐受性均显著高于GoLYTELY。
- 分次给药与更好的肠道清洁相关,男性、阿片类和三环类抗抑郁药使用者、糖尿病和肝硬化患者清洁更差。
核心结论
- 在这项前瞻性真实世界比较有效性研究中,MiraLAX联合Gatorade、MoviPrep和Suprep与更优的耐受性和肠道清洁前瞻性相关。
研究设计与样本
- 前瞻性、无商业资助的比较有效性研究,纳入年龄≥18岁、在大医疗中心接受门诊结肠镜检查的患者,该中心有超过70名学术和社区内镜医师可自由选择肠道准备方案。
- 约4339例结肠镜检查由75名内镜医师完成。
- 主要结局为波士顿肠道准备量表测量的肠道清洁质量,采用随机效应回归模型调整混杂因素。
主要发现
- 镁 citrate、MiraLAX联合Gatorade、MoviPrep、OsmoPrep、Prepopik/Clenpiq和Suprep的耐受性均显著高于GoLYTELY(所有P < 0.05)。
- Suprep(7.28 ± 1.66;P < 0.001)、MoviPrep(7.11 ± 1.62;P = 0.004)和MiraLAX联合Gatorade(7.09 ± 1.64;P < 0.001)的波士顿肠道准备量表总分高于GoLYTELY(6.67 ± 1.87);其余准备方案之间无显著差异。
- 分次给药与更好的清洁相关;然而,男性、阿片类和三环类抗抑郁药使用者、糖尿病和肝硬化患者清洁更差(所有P < 0.05)。
关键数值与推荐
- Suprep总分7.28 ± 1.66,P < 0.001;MoviPrep总分7.11 ± 1.62,P = 0.004;MiraLAX联合Gatorade总分7.09 ± 1.64,P < 0.001;均与GoLYTELY总分6.67 ± 1.87比较。
- 镁 citrate、MiraLAX联合Gatorade、MoviPrep、OsmoPrep、Prepopik/Clenpiq和Suprep的耐受性均显著高于GoLYTELY(所有P < 0.05)。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: National societies provide little guidance regarding which colonoscopy bowel preps are best tolerated and most effective; this reflects a lack of comparative effectiveness studies that directly evaluate the available preps in a "real-world" setting. To address this gap, we conducted a prospective, commercially unfunded comparative effectiveness study of currently available bowel preps and measured their impact on bowel cleansing. METHODS: We included patients aged ≥18 years, who presented for an outpatient colonoscopy at a large medical center serving more than 70 academic and community-based endoscopists who are free to prescribe the bowel prep of their choice. The primary outcome was bowel cleansing quality as measured by the Boston Bowel Preparation Scale. We performed regression models with random effects on the outcomes to adjust for confounding. RESULTS: Approximately 4,339 colonoscopies were performed by 75 endoscopists. Magnesium citrate, MiraLAX with Gatorade, MoviPrep, OsmoPrep, Prepopik/Clenpiq, and Suprep all had significantly higher prep tolerability compared with GoLYTELY (all P < 0.05). For bowel cleansing, Suprep (7.28 ± 1.66; P < 0.001), MoviPrep (7.11 ± 1.62; P = 0.004), and MiraLAX with Gatorade (7.09 ± 1.64; P < 0.001) had higher total Boston Bowel Preparation Scale scores compared with GoLYTELY (6.67 ± 1.87); there were no significant differences among the remaining preps. Split-prep dosing was associated with better cleansing; however, men, opioid and tricyclic antidepressent users, and patients with diabetes and cirrhosis had worse cleansing (all P < 0.05). CONCLUSIONS: In this prospective, real-world comparative effectiveness study of available bowel preps, we found that MiraLAX with Gatorade, MoviPrep, and Suprep were prospectively associated with superior tolerability and bowel cleansing.
引用
- Gu P, Lew D, Oh SJ, et al. Comparing the Real-World Effectiveness of Competing Colonoscopy Preparations: Results of a Prospective Trial. Am J Gastroenterol. 2019. PMID: 30730859. doi:10.14309/ajg.0000000000000057
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。